Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis
Objectives. Hypothalamic-Pituitary-Adrenal axis function may be abnormal in rheumatoid arthritis (RA). A pilot study in 7 patients suggested impaired glucocorticoid feedback in some patients after the dexamethasone-corticotrophin releasing hormone (CRH) test. This study aimed to investigate the dexa...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2009/391284 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849308623657762816 |
|---|---|
| author | Eman A. Hasan David S. Jessop Lynsey L. Power Paul T. Monk John R. Kirwan |
| author_facet | Eman A. Hasan David S. Jessop Lynsey L. Power Paul T. Monk John R. Kirwan |
| author_sort | Eman A. Hasan |
| collection | DOAJ |
| description | Objectives. Hypothalamic-Pituitary-Adrenal axis function may be abnormal in rheumatoid arthritis (RA). A pilot study in 7 patients suggested impaired glucocorticoid feedback in some patients after the dexamethasone-corticotrophin releasing hormone (CRH) test. This study aimed to investigate the dexamethasone-corticotrophin releasing factor test in a larger group of patients and relate the results to characteristics of the disease. Methods. Outpatients with active RA (≥3 swollen and tender joints and C-reactive protein > 10 mg/L) took dexamethasone (1.5 mg) at 23:00 hour in the evening. Next day, baseline saliva and plasma samples were collected, CRH was infused at 11:00 hour, and 4 serial blood and saliva samples were collected. Plasma samples were stored at −80∘C and a radioimmunoassay performed for saliva and plasma cortisol.
Results. All 20 participants showed normal dexamethasone suppression and mounted no response to the CRH challenge. In samples with measurable cortisol, there was a strong correlation between saliva and plasma values (r = 0.876, n = 26, P<.01). Conclusion. No abnormalities were found in the Dexamethasone-CRH test in RA patients in contrast to a previous pilot study. Salivary cortisol measurement may offer an alternative noninvasive technique to plasma cortisol in RA patients in future studies. |
| format | Article |
| id | doaj-art-0d7e3bf1a2a7490ab92be641d5902536 |
| institution | Kabale University |
| issn | 1687-8337 1687-8345 |
| language | English |
| publishDate | 2009-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Endocrinology |
| spelling | doaj-art-0d7e3bf1a2a7490ab92be641d59025362025-08-20T03:54:24ZengWileyInternational Journal of Endocrinology1687-83371687-83452009-01-01200910.1155/2009/391284391284Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid ArthritisEman A. Hasan0David S. Jessop1Lynsey L. Power2Paul T. Monk3John R. Kirwan4The Academic Rheumatology Unit, University of Bristol, UKWelcome Laboratories for Integrative Neuroscience and Endocrinology, University of Bristol, UKThe Academic Rheumatology Unit, University of Bristol, UKThe Academic Rheumatology Unit, University of Bristol, UKThe Academic Rheumatology Unit, University of Bristol, UKObjectives. Hypothalamic-Pituitary-Adrenal axis function may be abnormal in rheumatoid arthritis (RA). A pilot study in 7 patients suggested impaired glucocorticoid feedback in some patients after the dexamethasone-corticotrophin releasing hormone (CRH) test. This study aimed to investigate the dexamethasone-corticotrophin releasing factor test in a larger group of patients and relate the results to characteristics of the disease. Methods. Outpatients with active RA (≥3 swollen and tender joints and C-reactive protein > 10 mg/L) took dexamethasone (1.5 mg) at 23:00 hour in the evening. Next day, baseline saliva and plasma samples were collected, CRH was infused at 11:00 hour, and 4 serial blood and saliva samples were collected. Plasma samples were stored at −80∘C and a radioimmunoassay performed for saliva and plasma cortisol. Results. All 20 participants showed normal dexamethasone suppression and mounted no response to the CRH challenge. In samples with measurable cortisol, there was a strong correlation between saliva and plasma values (r = 0.876, n = 26, P<.01). Conclusion. No abnormalities were found in the Dexamethasone-CRH test in RA patients in contrast to a previous pilot study. Salivary cortisol measurement may offer an alternative noninvasive technique to plasma cortisol in RA patients in future studies.http://dx.doi.org/10.1155/2009/391284 |
| spellingShingle | Eman A. Hasan David S. Jessop Lynsey L. Power Paul T. Monk John R. Kirwan Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis International Journal of Endocrinology |
| title | Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis |
| title_full | Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis |
| title_fullStr | Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis |
| title_full_unstemmed | Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis |
| title_short | Use of the Dexamethasone-Corticotrophin Releasing Hormone Test to Assess Hypothalamic-Pituitary-Adrenal Axis Function in Rheumatoid Arthritis |
| title_sort | use of the dexamethasone corticotrophin releasing hormone test to assess hypothalamic pituitary adrenal axis function in rheumatoid arthritis |
| url | http://dx.doi.org/10.1155/2009/391284 |
| work_keys_str_mv | AT emanahasan useofthedexamethasonecorticotrophinreleasinghormonetesttoassesshypothalamicpituitaryadrenalaxisfunctioninrheumatoidarthritis AT davidsjessop useofthedexamethasonecorticotrophinreleasinghormonetesttoassesshypothalamicpituitaryadrenalaxisfunctioninrheumatoidarthritis AT lynseylpower useofthedexamethasonecorticotrophinreleasinghormonetesttoassesshypothalamicpituitaryadrenalaxisfunctioninrheumatoidarthritis AT paultmonk useofthedexamethasonecorticotrophinreleasinghormonetesttoassesshypothalamicpituitaryadrenalaxisfunctioninrheumatoidarthritis AT johnrkirwan useofthedexamethasonecorticotrophinreleasinghormonetesttoassesshypothalamicpituitaryadrenalaxisfunctioninrheumatoidarthritis |